(Q45357002)

13 December 2017

Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies (English)

1 reference

13 December 2017

1 reference

1 reference

17

1 reference

13 December 2017

Changhua Ji

1

1 reference

13 December 2017

Konduru S R Sastry

2

1 reference

13 December 2017

Georg Tiefenthaler

3

1 reference

13 December 2017

Jennifer Cano

4

1 reference

13 December 2017

Tenny Tang

5

1 reference

13 December 2017

Zi Zong Ho

6

1 reference

13 December 2017

Denise Teoh

7

1 reference

13 December 2017

Sandhya Bohini

8

1 reference

13 December 2017

Antony Chen

9

1 reference

13 December 2017

Surya Sankuratri

10

1 reference

13 December 2017

Paul A Macary

11

1 reference

13 December 2017

Patrick Kennedy

12

1 reference

13 December 2017

Han Ma

13

1 reference

13 December 2017

Stefan Ries

14

1 reference

13 December 2017

Klaus Klumpp

15

1 reference

13 December 2017

Erhard Kopetzki

16

1 reference

13 December 2017

language of work or name

English

0 references

publication date

12 July 2012

1 reference

13 December 2017

1 reference

13 December 2017

56

1 reference

13 December 2017

6

1 reference

13 December 2017

2027-2038

1 reference

Hepatitis B Virus Infection

13 December 2017

1 reference

Type I interferon: friend or foe?

21 January 2018

1 reference

Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B.

21 January 2018

1 reference

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Inhibition of Alpha Interferon Signaling by Hepatitis B Virus

21 January 2018

1 reference

Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

21 January 2018

1 reference

Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection

21 January 2018

1 reference

Adenovirus-mediated gene transfer of interferon α improves dimethylnitrosamine-induced liver cirrhosis in rat model

21 January 2018

1 reference

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody

21 January 2018

1 reference

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

21 January 2018

1 reference

Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture.

21 January 2018

1 reference

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

21 January 2018

1 reference

Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).

21 January 2018

1 reference

Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C.

21 January 2018

1 reference

Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.

21 January 2018

1 reference

TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.

21 January 2018

1 reference

Differential receptor subunit affinities of type I interferons govern differential signal activation.

21 January 2018

1 reference

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

21 January 2018

1 reference

Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1.

21 January 2018

1 reference

CD4-anchoring HIV-1 fusion inhibitor with enhanced potency and in vivo stability.

21 January 2018

1 reference

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

21 January 2018

1 reference

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

21 January 2018

1 reference

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma

21 January 2018

1 reference

Hepatitis B virus infection

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.25875

1 reference

13 December 2017

1 reference